Skip to main content
One Health logoLink to One Health
editorial
. 2020 Jun 25;10:100147. doi: 10.1016/j.onehlt.2020.100147

Importance of the One Health approach to study the SARS-CoV-2 in Latin America

D Katterine Bonilla-Aldana a,b, Yeimer Holguin-Rivera b, Soffia Perez-Vargas a, Adrian E Trejos-Mendoza a, Graciela J Balbin-Ramon c,d, Kuldeep Dhama e, Paola Barato f, Charlene Lujan-Vega g,h, Alfonso J Rodriguez-Morales b,c,i,j,
PMCID: PMC7315149  PMID: 32665970

1. Introduction

The Coronavirus Disease 2019 (COVID-19) pandemic, due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continuing and is currently raging in Latin America [[1], [2], [3], [4]]. In this region (including the Caribbean), up to July 3, 2020, 2,746,277 cases have been reported, more than 2,358,756 of them in South America, and 1,496,858 just in Brazil [5,6]. This, the largest country in the region, have reported 61,884 deaths (4.13%). Mexico, the second largest country, has a higher proportion of deaths, 29,189 out of 238,511 (12.23%). On the other side, Chile, although have reported 288,089 cases, only 6,051 deaths have registered (2.1%) [5,6]. In the case of Venezuela, this a country where doubts about the numbers have been raised. Up to July 3, 2020, 6,273 cases have been reported, but, this number could be underestimated because of under-testing and under-reporting [7]. In the region, there have been clear differences in the responses to the disease, with countries such as Colombia, Peru, Bolivia, Chile, Argentina, among others following wide recommendations of quarantine, physical distance and biosecurity education in an early stage of the pandemic, whilst in others such as Brazil or Mexico, this has been delayed, with very well-known consequences. In Brazil, the poorly-urbanized neighborhoods on the margins of city centers, the so called favelas, are focal points for the disease, with precarious living conditions and high population density making social distancing a near-impossibility [8].

The coronaviruses (CoVs) are pathogens that can be transmitted between and infecting in both humans and animals. These have a worldwide distribution [[9], [10], [11], [12], [13]]. Due to the importance of the SARS-CoV-2 outbreak that started in Wuhan, province of Hubei, China, the World Health Organization (WHO) declared this viral infection as a health emergency of international concern and later as a pandemic [[14], [15], [16], [17], [18], [19], [20]]. Taxonomically, this virus is an enveloped single-stranded RNA virus, which belongs to the subgenus Sarbecovirus, part of the genus Betacoronavirus (order Nidovirales; suborder Cornidovirineae; family Coronaviridae; subfamily Coronavirinae). In the subgenus Sarbecovirus, is also included the SARS-CoV, the etiological agent of the 2002–2003 epidemic originated in Guandong, China [[21], [22], [23]]. For One Health, viruses among the Coronaviridae family are archetypal [24]. The virus shares a high level of identity with some bat coronaviruses and is recognized as a zoonotic virus [24,25].

The virological and epidemiological scenario of this pandemic is complex, and still, many questions remain unanswered. Animal infection due to zoonotic coronaviruses has been previously reported on a farm and domestic animals such as cattle, pigs, dogs, among others [26]. This probably have been occurring for years, and not only in animals but in asymptomatic humans. Nevertheless, the first significant and apparent report in humans was described in 2002 in Guangzhou, province of Guangdong, China, where more than eight thousand cases were confirmed due to a new virus, causing 774 deaths in 32 countries around the world [27]. That virus was the SARS-CoV [[27], [28], [29], [30], [31]]. Later in 2012, another outbreak of a zoonotic coronavirus was reported. The Middle East Respiratory Syndrome coronavirus (MERS-CoV), originated in Saudi Arabia, also spread to other Asian, African, European, and American countries, also causing deaths [11,[32], [33], [34]].

In the case of the SARS-CoV, it was shown that the outbreak originated due to the transmission of the Himalayan civet (Paguma larvata) [30]. However, it was also reported that animal species such as raccoons and bats could carry the virus [30]. In the case of MERS-CoV, after identifying the virus, the epidemiological relationship between human and camel cases was confirmed [[34], [35], [36]]. Both SARS-CoV and MERS-CoV have caused more than 10,000 cumulative cases in the past two decades, with case fatality rates of 10% and 37%, respectively [[34], [35], [36]]. The identified coronaviruses were the tip of the iceberg. More of them would emerge and become apparent as already occurred with the current pandemic SARS-CoV-2/COVID-19 [11,12,23]. In this scenario of interaction between animal and human health, also the environmental health, then, the concept of One Health, is again of utmost importance. One Health is an approach that recognizes that the health of people is closely connected to the health of animals and our shared environment (Fig. 1). Currently at homes, zoological parks and farms, there have been reports of infections from humans to animals. At homes, cats and dogs; at zoological parks, tigers and lions; and at farms, minks (Fig. 1) [[37], [38], [39], [40]].

Fig. 1.

Fig. 1

Proposed current evidence-based interactions between animal, human, and environmental components in the context of SARS-CoV-2 transmission.

At the integrative disease ecology study of SARS-CoV-2/COVID-19, its relevance seems to be more than evident. Notably, at the beginning of the pandemic, during the first identified spillover between animals and humans, at the Huanan Seafood Wholesale Market in Wuhan or in the suburban-wild interphases or ecotones that probably allow the interaction between SARS-CoV-2 infected animals and humans, this should be a relevant factor (Fig. 1). Current evidence is showing that the SARS-CoV-2 would be transmitted from humans to domestic cats at home, as well as to wild felids in zoological parks (Fig. 1), without evidence of transmission from these animals to humans [26,37,[41], [42], [43], [44]].

2. Animals

Nevertheless, at this moment we do not know the real susceptibility of animals to SARS-CoV-2 exposure, including the role of the inoculum, the route of transmission, among other related factors. In the current scenario of significant human-to-human transmission appear as the main focus to be attended, and the role of animals would be seen as marginal, but this deserves a comprehensive approach and assessment to understand the epidemiology and future advance of disease. If individual animals became reservoirs or vehicles of SARS-CoV-2, this infection might become endemic. In the case of South America, as yet, so not reports of transmission from human to animals have been made, nevertheless, in addition to dogs, cats, tigers and lions, maybe there is concern about infection in Mustelidae from South America [45], but this is yet to be seen and reported.

3. Environment and degradation

In the context of COVID-19 pandemic, the presence of SARS-CoV-2 in wastewater has been consider as a potential health risk, but also as an effective approach to predict the potential spread of the infection by testing for infectious agents in wastewater [[46], [47], [48], [49]]. Given that plumbed wastewater is not universal and in places such as suburban areas of cities in northeastern Brazil, a lot of human waste is pumped directly into lakes and streams. Recently, more studies are showing the detection of SARS-CoV-2 in wastewater [[50], [51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61]]. In other countries of South America the situation is even more complicated as there are not enough wastewater treatment plants with its consequent implications, including the SARS-CoV-2 context.

In the environmental context, the impact of climate change and land use, including deforestation and intensive farming practices, should also be analyzed [62]. Disruptions in environmental conditions and habitats can provide new opportunities for SARS-CoV-2 and maybe other CoVs to spillover. Given the great abundance of non-human primates in South America, especially in Rio de Janeiro, where tourists are in close contact,  with callitrichid monkeys, and there is recent evidence indicating that rhesus macaques are susceptible to SARS-CoV-2 [63]. Human cases in these niches are a matter of concern. Species of mustelids, canids and felids from the order Carnivora are known to be SARS-CoV-2 positive. In Iguazu, Argentina, tourists are in close contact with coatis, a species of procyonid from the order Carnivora [64]. Although at this moment there is no evidence of any procyonid species host SARS-CoV-2, close contact with humans could be an issue in this region.

In the case of Latin America such disruptions have been seen especially in the Amazon jungle, an area shared not only with Brazil, but with many other countries in South America, observing the impact on zoonotic and vector-borne diseases and pathogens, such as malaria, dengue, chikungunya, Zika, hantavirus, hemorrhagic viral fevers [62,[65], [66], [67]].

4. Conclusions

Health programs targeting an integrative approach for COVID-19 should consider the role of One Health initiatives [9,68]. Operative research on animals in close contact with positive SARS-CoV-2 humans, beginning with those at home or in zoological parks, such as dogs, pets, ferrets among others, should be studied, as recent evidence suggests the possible human-to-felines and human-to-dogs transmission (Fig. 1) [[69], [70], [71], [72]]. Many unanswered questions need to be carefully studied with ONE HEALTH approach [73]. This would be helpful for a better understanding of SARS-CoV-2/COVID-19 epidemiology, transmission, dynamics, and disease ecology. In Colombia, associations such as the Colombian Association of Veterinarians Attending Small Animals (VEPA), are promoting discussions around SARS-CoV-2 and the importance of One Health, to inform the society about the evidences regarding transmission in some domestic animals, felines, including cats, lions, and tigers, as well as to promote the development of expert panels; also, these discussions including the evaluation of capacities of veterinary molecular laboratories in case that could be needed support to SARS-CoV-2 diagnosis in humans [74]. In Peru, the College of Veterinary Medicine, is developing statements and providing recommendations especially for the health authorities. In Chile, the Chilean Society of Zoonoses has been working in wide diffusion of information and education to population regarding human and animal implications of the SARS-CoV-2/COVID-19 pandemic. In Brazil, the Brazilian Society of Zoology is developing online training courses, conferences and symposia directly targeted to the One Health approach in the context of the SARS-CoV-2/COVID-19 pandemic. Unfortunate, in countries such as Venezuela, there is a lack of responses directly targeting these approaches. Furthermore, multiple teams composed by engineers, biologists, physicists, veterinarians, public health professionals are making efforts to develop Colombian and Peruvian products such as mechanical ventilators, N95 masks, and ozone cabinets to aid to contain the effects of this disease. However, not in all cases there is an integration of combining the knowledge from a multidisciplinary and multi-institutional team.

Health is one. Now is time to make this critical message to deliver to health authorities and society. The study and control of all emerging and zoonotic diseases require this approach. It will benefit the understanding and the opportunities to deploy early interventions and mitigate the profound impacts, a pandemic of zoonotic origin has.

References

  • 1.Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.The L. Emerging understandings of 2019-nCoV. Lancet. 2020;395:311. doi: 10.1016/S0140-6736(20)30186-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Wang C., Horby P.W., Hayden F.G., Gao G.F. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470–473. doi: 10.1016/S0140-6736(20)30185-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Dong E., Du H., Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 2020;20(5):533–534. doi: 10.1016/S1473-3099(20)30120-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cimerman S., Chebabo A., CAd Cunha, Rodríguez-Morales A.J. Deep impact of COVID-19 in the healthcare of Latin America: the case of Brazil. Braz. J. Infect. Dis. 2020;24(2):93–95. doi: 10.1016/j.bjid.2020.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Paniz-Mondolfi A.E., Sordillo E.M., Marquez-Colmenarez M.C., Delgado-Noguera L.A., Rodriguez-Morales A.J. The arrival of SARS-CoV-2 in Venezuela. Lancet. 2020;395:e85–e86. doi: 10.1016/S0140-6736(20)31053-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Scalzaretto N. 2020. Mapping the Covid-19 spread in Brazilian favelas.https://brazilian.report/coronavirus-brazil-live-blog/2020/04/20/mapping-covid-19-spread-brazilian-favelas/ [Google Scholar]
  • 9.Bonilla-Aldana D.K., Dhama K., Rodriguez-Morales A.J. Revisiting the one health approach in the context of COVID-19: a look into the ecology of this emerging disease. Adv Anim Vet Sci. 2020;8:234–237. [Google Scholar]
  • 10.Bonilla-Aldana D.K., Quintero-Rada K., Montoya-Posada J.P., Ramirez-Ocampo S., Paniz-Mondolfi A., Rabaan A.A. SARS-CoV, MERS-CoV and now the 2019-novel CoV: have we investigated enough about coronaviruses? - a bibliometric analysis. Travel Med. Infect. Dis. 2020;33 doi: 10.1016/j.tmaid.2020.101566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Bonilla-Aldana D.K., Villamil-Gómez W.E., Rabaan A.A., Rodriguez-Morales A.J. Una nueva zoonosis viral de preocupación global: COVID-19, enfermedad por coronavirus 2019. Iatreia. 2020;33:107–110. [Google Scholar]
  • 12.Rodriguez-Morales A.J., Bonilla-Aldana D.K., Balbin-Ramon G.J., Paniz-Mondolfi A., Rabaan A., Sah R. History is repeating itself, a probable zoonotic spillover as a cause of an epidemic: the case of 2019 novel coronavirus. Infez Med. 2020;28:3–5. [PubMed] [Google Scholar]
  • 13.El Zowalaty M.E., Jarhult J.D. From SARS to COVID-19: a previously unknown SARS- related coronavirus (SARS-CoV-2) of pandemic potential infecting humans - call for a one health approach. One Health. 2020;9 doi: 10.1016/j.onehlt.2020.100124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.World Health Organization One Health. 2017. http://www.who.int/features/qa/one-health/en/
  • 15.World Health Organization. Novel Coronavirus (2019-nCoV) - Situation Report - 4 - 24 January 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200124-sitrep-4-2019-ncov.pdf?sfvrsn=9272d086_2. 2020.
  • 16.World Health Organization . 2020. Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV) https://www.who.int/news-room/detail/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) [Google Scholar]
  • 17.World Health Organization Novel Coronavirus (2019-nCoV) - Situation Report - 7 - 27 January 2020. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200127-sitrep-7-2019--ncov.pdf?sfvrsn=98ef79f5_2020
  • 18.World Health Organization . 2020. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV) https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) [Google Scholar]
  • 19.World Health Organization. Novel Coronavirus (2019-nCoV) - Situation Report - 10 - 30 January 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf?sfvrsn=d0b2e480_2. 2020.
  • 20.World Health Organization. Pneumonia of Unknown Cause – China. https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-china/en/. 2020.
  • 21.Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17:181–192. doi: 10.1038/s41579-018-0118-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Dhama K., Sharun K., Tiwari R., Sircar S., Bhat S., Malik Y.S. Coronavirus disease 2019 – COVID-19. Clin Microbiol Rev. 2020;33(4):e00028–20. doi: 10.1128/CMR.00028-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Millan-Oñate J., Rodríguez-Morales A.J., Camacho-Moreno G., Mendoza-Ramírez H., Rodríguez-Sabogal I.A., Álvarez-Moreno C. A new emerging zoonotic virus of concern: the 2019 novel coronavirus (COVID-19) Infectio. 2020;24:187–192. [Google Scholar]
  • 24.Marty A.M., Jones M.K. The novel coronavirus (SARS-CoV-2) is a one health issue. One Health. 2020;9 doi: 10.1016/j.onehlt.2020.100123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hemida M.G., Ba Abduallah M.M. The SARS-CoV-2 outbreak from a one health perspective. One Health. 2020 doi: 10.1016/j.onehlt.2020.100127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Tiwari R., Dhama K., Sharun K., Iqbal Yatoo M., Malik Y.S., Singh R. COVID-19: animals, veterinary and zoonotic links. Vet Q. 2020;40:169–182. doi: 10.1080/01652176.2020.1766725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gumel A.B., Ruan S., Day T., Watmough J., Brauer F., van den Driessche P. Modelling strategies for controlling SARS outbreaks. Proc. Biol. Sci. 2004;271:2223–2232. doi: 10.1098/rspb.2004.2800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Leung G.M., Chung P.H., Tsang T., Lim W., Chan S.K., Chau P. SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg. Infect. Dis. 2004;10:1653–1656. doi: 10.3201/eid1009.040155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Chen W., Yan M., Yang L., Ding B., He B., Wang Y. SARS-associated coronavirus transmitted from human to pig. Emerg. Infect. Dis. 2005;11:446–448. doi: 10.3201/eid1103.040824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Wang L.F., Eaton B.T. Bats, civets and the emergence of SARS. Curr. Top. Microbiol. Immunol. 2007;315:325–344. doi: 10.1007/978-3-540-70962-6_13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Tong S., Conrardy C., Ruone S., Kuzmin I.V., Guo X., Tao Y. Detection of novel SARS-like and other coronaviruses in bats from Kenya. Emerg. Infect. Dis. 2009;15:482–485. doi: 10.3201/eid1503.081013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Al-Omari A., Rabaan A.A., Salih S., Al-Tawfiq J.A., Memish Z.A. MERS coronavirus outbreak: implications for emerging viral infections. Diagn. Microbiol. Infect. Dis. 2019;93:265–285. doi: 10.1016/j.diagmicrobio.2018.10.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Chu D.K., Poon L.L., Gomaa M.M., Shehata M.M., Perera R.A., Abu Zeid D. MERS coronaviruses in dromedary camels, Egypt. Emerg. Infect. Dis. 2014;20:1049–1053. doi: 10.3201/eid2006.140299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Corman V.M., Jores J., Meyer B., Younan M., Liljander A., Said M.Y. Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg. Infect. Dis. 2014;20:1319–1322. doi: 10.3201/eid2008.140596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Islam A., Epstein J.H., Rostal M.K., Islam S., Rahman M.Z., Hossain M.E. Middle East respiratory syndrome coronavirus antibodies in dromedary camels, Bangladesh, 2015. Emerg. Infect. Dis. 2018;24:926–928. doi: 10.3201/eid2405.171192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Muller M.A., Corman V.M., Jores J., Meyer B., Younan M., Liljander A. MERS coronavirus neutralizing antibodies in camels, eastern Africa, 1983-1997. Emerg. Infect. Dis. 2014;20:2093–2095. doi: 10.3201/eid2012.141026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Halfmann P.J., Hatta M., Chiba S., Maemura T., Fan S., Takeda M. Transmission of SARS-CoV-2 in domestic cats. N. Engl. J. Med. 2020 doi: 10.1056/NEJMc2013400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Enserik M. Coronavirus rips through Dutch mink farms, triggering culls to prevent human infections. Science. 2020;368(6496):1169. doi: 10.1126/science.368.6496.1169. [DOI] [PubMed] [Google Scholar]
  • 39.Mallapaty S. Dogs caught coronavirus from their owners, genetic analysis suggests. Nature. 2020 doi: 10.1038/d41586-020-01430-5. [DOI] [PubMed] [Google Scholar]
  • 40.APHIS. Confirmed Cases of SARS-CoV-2 in Animals in the United States. https://www.aphis.usda.gov/aphis/ourfocus/animalhealth/sa_one_health/sars-cov-2-animals-us. 2020.
  • 41.Wang L., Mitchell P.K., Calle P.P., Bartlett S.L., McAloose D., Killian M.L. Complete genome sequence of SARS-CoV-2 in a Tiger from a U.S. zoological collection. Microbiol Resour Announc. 2020;9 doi: 10.1128/MRA.00468-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Shi J., Wen Z., Zhong G., Yang H., Wang C., Huang B. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 2020;368:1016–1020. doi: 10.1126/science.abb7015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Li X. Cats under the shadow of the SARS-CoV-2 pandemic. Transbound. Emerg. Dis. 2020 doi: 10.1111/tbed.13599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Rodriguez-Morales A.J., Dhama K., Sharun K., Tiwari R., Bonilla-Aldana D.K. Susceptibility of felids to coronaviruses. Vet. Rec. 2020;186(17):e21. doi: 10.1136/vr.m1671. [DOI] [PubMed] [Google Scholar]
  • 45.Vieira F.M., Muniz-Pereira L.C., de Souza L.S., Neto A.H., Goncalves P.R., Luque J.L. Crenosoma brasiliense sp. n. (Nematoda: Metastrongyloidea) parasitic in lesser grison, Galictis cuja (Molina, 1782) (Carnivora, Mustelidae) from Brazil, with a key to species of Crenosoma Molin, 1861. Folia Parasitol. 2012;59:187–194. doi: 10.14411/fp.2012.026. [DOI] [PubMed] [Google Scholar]
  • 46.Lodder W., de Roda Husman A.M. SARS-CoV-2 in wastewater: potential health risk, but also data source. Lancet Gastroenterol Hepatol. 2020;5:533–534. doi: 10.1016/S2468-1253(20)30087-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Mao K., Zhang H., Yang Z. Can a paper-based device trace COVID-19 sources with wastewater-based epidemiology? Environ. Sci. Technol. 2020;54:3733–3735. doi: 10.1021/acs.est.0c01174. [DOI] [PubMed] [Google Scholar]
  • 48.Wu S., Wang Y., Jin X., Tian J., Liu J., Mao Y. Environmental contamination by SARS-CoV-2 in a designated hospital for coronavirus disease 2019. Am. J. Infect. Control. 2020 doi: 10.1016/j.ajic.2020.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Wu F., Xiao A., Zhang J., Gu X., Lee W.L., Kauffman K. SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases. medRxiv. 2020 doi: 10.1101/2020.04.05.20051540. 2020.04.05.20051540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Ahmed W., Angel N., Edson J., Bibby K., Bivins A., O’Brien J.W. First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: a proof of concept for the wastewater surveillance of COVID-19 in the community. Sci. Total Environ. 2020;728 doi: 10.1016/j.scitotenv.2020.138764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Daughton C.G. Wastewater surveillance for population-wide Covid-19: The present and future. Sci. Total Environ. 2020;736 doi: 10.1016/j.scitotenv.2020.139631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Gormley M., Aspray T.J., Kelly D.A. COVID-19: mitigating transmission via wastewater plumbing systems. Lancet Glob. Health. 2020;8:e643. doi: 10.1016/S2214-109X(20)30112-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Hart O.E., Halden R.U. Computational analysis of SARS-CoV-2/COVID-19 surveillance by wastewater-based epidemiology locally and globally: feasibility, economy, opportunities and challenges. Sci. Total Environ. 2020;730 doi: 10.1016/j.scitotenv.2020.138875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Hata A., Honda R. Potential sensitivity of wastewater monitoring for SARS-CoV-2: comparison with norovirus cases. Environ. Sci. Technol. 2020;54:6451–6452. doi: 10.1021/acs.est.0c02271. [DOI] [PubMed] [Google Scholar]
  • 55.Manoj K. Wastewater monitoring and public health surveillance of SARS-CoV-2. Indian J. Public Health. 2020;64 doi: 10.4103/ijph.IJPH_490_20. S247-S48. [DOI] [PubMed] [Google Scholar]
  • 56.Murakami M., Hata A., Honda R., Watanabe T. Letter to the editor: wastewater-based epidemiology can overcome representativeness and stigma issues related to COVID-19. Environ. Sci. Technol. 2020;54:5311. doi: 10.1021/acs.est.0c02172. [DOI] [PubMed] [Google Scholar]
  • 57.Nemudryi A., Nemudraia A., Surya K., Wiegand T., Buyukyoruk M., Wilkinson R. Temporal detection and phylogenetic assessment of SARS-CoV-2 in municipal wastewater. medRxiv. 2020 doi: 10.1101/2020.04.15.20066746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Protection C.-E.R.K.P. Disinfection technology team CCfDC, prevention. [technical guideline for disinfection of wastewater and wastes of medical organizations during COVID-19 outbreak] Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54:353–356. doi: 10.3760/cma.j.cn112150-20200217-00125. [DOI] [PubMed] [Google Scholar]
  • 59.Randazzo W., Truchado P., Cuevas-Ferrando E., Simon P., Allende A., Sanchez G. SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area. Water Res. 2020;181 doi: 10.1016/j.watres.2020.115942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Venugopal A., Ganesan H., Sudalaimuthu Raja S.S., Govindasamy V., Arunachalam M., Narayanasamy A. Novel wastewater surveillance strategy for early detection of coronavirus disease 2019 hotspots. Curr Opin Environ Sci Health. 2020;17:8–13. doi: 10.1016/j.coesh.2020.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Wang J., Shen J., Ye D., Yan X., Zhang Y., Yang W. Disinfection technology of hospital wastes and wastewater: suggestions for disinfection strategy during coronavirus disease 2019 (COVID-19) pandemic in China. Environ. Pollut. 2020;262 doi: 10.1016/j.envpol.2020.114665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Bonilla-Aldana D.K., Suarez J.A., Franco-Paredes C., Vilcarromero S., Mattar S., Gomez-Marin J.E. Brazil burning! What is the potential impact of the Amazon wildfires on vector-borne and zoonotic emerging diseases? - a statement from an international experts meeting. Travel Med. Infect. Dis. 2019;31 doi: 10.1016/j.tmaid.2019.101474. [DOI] [PubMed] [Google Scholar]
  • 63.Munster V.J., Feldmann F., Williamson B.N., van Doremalen N., Perez-Perez L., Schulz J. Respiratory disease in rhesus macaques inoculated with SARS-CoV-2. Nature. 2020 doi: 10.1038/s41586-020-2324-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Marotta M.F. Conflicto entre los coatíes (Nasua nasua) y los turistas del Parque Nacional Iguazú, Misiones, Argentina: evaluación de medidas de manejo tendientes a reducirlo. https://bibliotecadigital.exactas.uba.ar/download/seminario/seminario_nBIO001612_Marotta.pdf
  • 65.Escalera-Antezana J.P., Murillo-Garcia D.R., Rodriguez-Morales A.J. Chikungunya in Bolivia: still a neglected disease? Arch. Med. Res. 2018;49:288. doi: 10.1016/j.arcmed.2018.09.002. [DOI] [PubMed] [Google Scholar]
  • 66.Escalera-Antezana J.P., Rodriguez-Villena O.J., Arancibia-Alba A.W., Alvarado-Arnez L.E., Bonilla-Aldana D.K., Rodriguez-Morales A.J. Clinical features of fatal cases of Chapare virus hemorrhagic fever originating from rural La Paz, Bolivia, 2019: a cluster analysis. Travel Med. Infect. Dis. 2020 doi: 10.1016/j.tmaid.2020.101589. [DOI] [PubMed] [Google Scholar]
  • 67.Escalera-Antezana J.P., Torrez-Fernandez R., Montalvan-Plata D., Montenegro-Narvaez C.M., Aviles-Sarmiento J.L., Alvarado-Arnez L.E. Orthohantavirus pulmonary syndrome in Santa Cruz and Tarija, Bolivia, 2018. Int. J. Infect. Dis. 2020;90:145–150. doi: 10.1016/j.ijid.2019.10.021. [DOI] [PubMed] [Google Scholar]
  • 68.Dhama K., Chakraborty S., S K., Tiwari R., Kumar A., R D. One world, one health - veterinary perspectives. Adv. Anim. Vet. Sci. 2013;1:5–13. [Google Scholar]
  • 69.OIE Questions and Answers on the 2019 Coronavirus Disease (COVID-19) 2020. https://www.oie.int/en/scientific-expertise/specific-information-and-recommendations/questions-and-answers-on-2019novel-coronavirus/
  • 70.OIE. Information Received on 06/04/2020 from Dr Mark Davidson, Associate Administrator, USDA-APHIS, United States Department of Agriculture, Washington, United States of America. https://www.oie.int/wahis_2/public/wahid.php/Reviewreport/Review?page_refer=MapFullEventReport&reportid=33885. 2020.
  • 71.Zhang Q., Zhang H., Huang K., Yang Y., Hui X., Gao J. SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation. bioRxiv. 2020 doi: 10.1101/2020.04.01.021196. 2020.04.01.021196. [DOI] [Google Scholar]
  • 72.Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B, et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2. Science. 2020:eabb7015. [DOI] [PMC free article] [PubMed]
  • 73.CDC COVID-19 and Animals. 2020. https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/animals.html
  • 74.OIE Testing of Human Diagnostic Specimens in Veterinary Laboratories. 2020. https://rr-americas.oie.int/en/news/veterinary-laboratory-support-to-the-public-health-response/

Articles from One Health are provided here courtesy of Elsevier

RESOURCES